CIK 0001936258
- Large accelerated filer
NewAmsterdam Pharma Co N.V.
Sign in to watch- Ticker
- NAMS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Netherlands
- Entity type
- Operating
- Phone
- 35 206 2971
- Business address
- GOOIMEER 2-35, NARRDEN, Netherlands, 1411 DC
- Former names
- NewAmsterdam Pharma Co B.V.
Securities
- NAMS Ordinary Shares Nasdaq
- NAMSW Warrant Nasdaq
- 4 Open-market buy Director bought 8,584 shares at $19.50 ($167,381)
- 4 Grant or award See Remarks acquired 55,000 shares (grant or award)
- 4 Option exercise Director acquired 68 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Chief Operating Officer sold 100,000 shares
- 4 Derivatives Options or other derivatives
- 4 Option exercise Director acquired 69 shares (option exercise)
- 4 Option exercise Director acquired 69 shares (option exercise)
- 4 Planned sale Chief Operating Officer sold 100,000 shares
- 4 Grant or award Director acquired 10,860 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 1,135 shares at $22.49 ($25,521)
- 4 Option exercise Chief Accounting Officer acquired 8,269 shares (option exercise)
- 4 Option exercise Director acquired 3,102 shares (option exercise)
- 4 Grant or award Chief Scientific Officer acquired 19,302 shares (grant or award)
- 4 Open-market sale Chief Operating Officer sold 16,539 shares
- 4 Open-market sale Chief Executive Officer sold 12,258 shares
- 4 Option exercise Chief Scientific Officer acquired 150,000 shares (option exercise)
- 4 Planned sale Chief Operating Officer sold 100,000 shares
- 4 Open-market buy Director bought 4,005 shares at $21.02 ($84,203)
Page 3 of 7 · 132 filings